Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England.
Tam, Clarence C;
Higgins, Craig D;
Neal, Keith R;
Rodrigues, Laura C;
Millership, Sally E;
O'Brien, Sarah J;
Campylobacter Case-Control Study Group;
(2009)
Chicken consumption and use of acid-suppressing medications as risk factors for Campylobacter enteritis, England.
Emerging infectious diseases, 15 (9).
pp. 1402-1408.
ISSN 1080-6040
DOI: https://doi.org/10.3201/eid1509.080773
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
In a case-control study of Campylobacter spp. risk factors in England during 2005-2006, we identified recent consumption of commercially prepared chicken as an important risk factor. The risk for illness associated with recent chicken consumption was much lower for persons who regularly ate chicken than in those who did not, which suggests that partial immunologic protection may follow regular chicken preparation or consumption. Chicken-related risk factors accounted for 41% of cases; acid-suppressing medication, for 10%; self-reported past Campylobacter enteritis, 2%; and recent acquisition of a pet dog, 1%. Understanding the risks associated with chicken from different sources will benefit strategies to reduce Campylobacter infections. Better characterization of immune correlates for Campylobacter infection is necessary to assess the relative importance of immunity and behavioral factors in determining risk.
